Skip to content
Recall Observatory FDA recall evidence

Drug product

EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS: Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.

D-0691-2017

March 12, 2017

Class I

Product summary

Firm
Meridian Medical Technologies a Pfizer Company
Event
Event 76789
Status
Ongoing
Classification
Class I
Quantity
92,544 2-pak (U.S.); 198,579 syringes (O.U.S.)
Official record key
drug-enforcement:D-0691-2017

Official wording

Reason: Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Code information: US lot 5GN767, expiration April 2017; lot 5GN773, expiration April 2017; lot 6GN215, expiration Sep 2017: INTERNATIONAL lot 5GR765, expiration March 2017; lot 5GK771, expiration April 2017; lot 5ED824, expiration April 2017; and lot 6ED117, expiration ***

Distribution pattern: Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication